Oireachtas Joint and Select Committees
Wednesday, 8 November 2017
Joint Oireachtas Committee on Health
Evaluating Orphan Drugs: Discussion (Resumed)
9:00 am
Rose Conway Walsh (Sinn Fein) | Oireachtas source
Surely part of the remit is to negotiate on that price and get that price as low as the HSE possibly can. I accept the expectation that the drug company would come in at a price that was fair and reasonable. However, if in the HSE's opinion it is not fair and reasonable, surely it would be then fair and reasonable to go back and inform the company that the price is unacceptable and ask it for its discounted price, not the initial one. The HSE did ask for a discounted price.
No comments